Literature DB >> 26375202

Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.

Hiroyuki Tomimitsu1, Akiko Ohta2, Masaki Nagai2, Motoko Nishina2, Shoichiro Ishihara3, Hitoshi Kohsaka4.   

Abstract

OBJECTIVES: This study aimed to investigate the clinical characteristics of polymyositis/dermatomyositis (PM/DM) in Japan by analyzing data from the nationwide registration system.
METHODS: The data of the registration system in 2009 were analyzed to investigate patient numbers, sex, clinical symptoms, therapies, complications, and prognosis of PM/DM.
RESULTS: The total number of PM/DM cases was approximately 17,000, and the female/male sex ratio was 2.7:1. Almost all patients improved as a result of therapy, but many suffered from sequelae such as muscle weakness.
CONCLUSIONS: The results characterize significant aspects of Japanese PM/DM patients. However, a further prospective survey is required to clarify the true epidemiology and natural history of PM/DM.

Entities:  

Keywords:  Clinical features; Epidemiology; Nationwide registration system; Polymyositis and dermatomyositis (PM/DM)

Mesh:

Year:  2015        PMID: 26375202     DOI: 10.3109/14397595.2015.1091137

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies.

Authors:  Mari Kamiya; Fumitaka Mizoguchi; Kimito Kawahata; Dengli Wang; Masahiro Nishibori; Jessica Day; Cynthia Louis; Ian P Wicks; Hitoshi Kohsaka; Shinsuke Yasuda
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

2.  Interleukin-23 as a therapeutic target for inflammatory myopathy.

Authors:  Natsuka Umezawa; Kimito Kawahata; Fumitaka Mizoguchi; Naoki Kimura; Yoko Yoshihashi-Nakazato; Nobuyuki Miyasaka; Hitoshi Kohsaka
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

3.  Rheumatic manifestations of COVID-19: a systematic review and meta-analysis.

Authors:  Jacopo Ciaffi; Riccardo Meliconi; Piero Ruscitti; Onorina Berardicurti; Roberto Giacomelli; Francesco Ursini
Journal:  BMC Rheumatol       Date:  2020-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.